Herwig-Ulf Meier-Kriesche
Overview
Explore the profile of Herwig-Ulf Meier-Kriesche including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
3048
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Moudgil A, Dharnidharka V, Lamb K, Meier-Kriesche H
Transplantation
. 2012 Nov;
95(2):319-25.
PMID: 23154211
Background: On October 2005, the Organ Procurement and Transplant Network implemented a new allocation policy for kidney transplants (KTX) from deceased donors (DD) ages <35 years to increase an access...
12.
Pfaller M, Neofytos D, Diekema D, Azie N, Meier-Kriesche H, Quan S, et al.
Diagn Microbiol Infect Dis
. 2012 Oct;
74(4):323-31.
PMID: 23102556
This analysis describes the epidemiology and outcomes of candidemia in patients enrolled in the Prospective Antifungal Therapy Alliance (PATH Alliance®) registry from 2004 to 2008. Overall, 4067 Candida isolates were...
13.
Steinbach W, Marr K, Anaissie E, Azie N, Quan S, Meier-Kriesche H, et al.
J Infect
. 2012 Aug;
65(5):453-64.
PMID: 22898389
Objectives: The study investigated the epidemiology and outcome of invasive aspergillosis (IA), an important cause of morbidity and mortality in immunocompromised patients. Methods: Cases of proven/probable IA from the Prospective...
14.
Azie N, Neofytos D, Pfaller M, Meier-Kriesche H, Quan S, Horn D
Diagn Microbiol Infect Dis
. 2012 Jul;
73(4):293-300.
PMID: 22789847
The Prospective Antifungal Therapy Alliance (PATH Alliance®) performed prospective surveillance of invasive fungal infections (IFIs) among patients hospitalized at 25 medical centers in North America between 2004 and 2008, collecting...
15.
Casey M, Meier-Kriesche H
Curr Opin Nephrol Hypertens
. 2011 Sep;
20(6):610-5.
PMID: 21885969
Purpose Of Review: The utilization of calcineurin inhibitors (CNI) in kidney transplantation has dramatically improved short-term outcomes but significant gains in long-term outcomes have proved elusive. Nephrotoxicity is the major...
16.
Claes K, Meier-Kriesche H, Schold J, Vanrenterghem Y, Halloran P, Ekberg H
Nephrol Dial Transplant
. 2011 May;
27(2):850-7.
PMID: 21617197
Background: The metabolic syndrome (MS) is an important risk factor for graft dysfunction and patient death after renal transplantation. The aim of this sub-analysis of the Symphony study was to...
17.
Schold J, Gregg J, Harman J, Hall A, Patton P, Meier-Kriesche H
Clin J Am Soc Nephrol
. 2011 May;
6(7):1760-7.
PMID: 21597030
Background And Objectives: Many factors have been shown to be associated with ESRD patient placement on the waiting list and receipt of kidney transplantation. Our study aim was to evaluate...
18.
Meier-Kriesche H, Merville P, Tedesco-Silva H, Heemann U, Kes P, Haller H, et al.
Transplantation
. 2011 Apr;
91(9):984-90.
PMID: 21464796
Background: Despite evidence of favorable long-term effects of mycophenolate mofetil (MMF) in renal transplantation, its introduction at different times posttransplant has not been studied in large cohorts. Methods: Single-organ renal...
19.
Lodhi S, Meier-Kriesche H
Nephrol Dial Transplant
. 2010 Dec;
26(1):15-7.
PMID: 21177522
No abstract available.
20.
Rehman S, Meier-Kriesche H, Scornik J
Transplantation
. 2010 Oct;
90(8):932.
PMID: 20962612
No abstract available.